Enoxacin, an antimicrobial fluoroquinolone with a 7-piperazinyl-1,8-naphthyridine skeleton, is a potent inhibitor of cytochrome P-450-mediated theophylline metabolism. The present study was designed to clarify, using seven enoxacin derivatives, the molecular characteristics of the fluoroquinolone responsible for the inhibition. Three derivatives with methyl-substituted 7-piperazine rings inhibited rat liver microsomal theophylline metabolism to 1,3-dimethyluric acid to an extent similar to that of enoxacin (50% inhibitory concentrations [IC 50 The drug-drug interaction between fluoroquinolone antibacterial agents and a bronchodilator theophylline has been widely recognized since Wijnands et al. (31) observed raised concentrations of theophylline in the plasma of patients concomitantly given enoxacin (ENX; the structure is given in Fig.  1 ). This interaction involves the reduced metabolic clearance resulting from inhibition of theophylline metabolism by ENX (32). In previous reports (19, 21), we indicated that a similar interaction can be seen in the rat model and suggested that the neighborhood of a 7-piperazine ring in the ENX molecule, in particular, positions 4Ј and 8 (nitrogen atoms; see Fig. 1 ), are of certain importance in this interaction. However, both in rats (19, 22) and in humans (23, 26, 29, 33) , the effects of other fluoroquinolones with 7-piperazine rings with structures similar to that of ENX are not always the same on in vitro and in vivo theophylline metabolism: ofloxacin and norfloxacin exhibit a slight interaction, and lomefloxacin and sparfloxacin, which are 6,8-difluorinated quinolones, scarcely affect theophylline metabolism.
The drug-drug interaction between fluoroquinolone antibacterial agents and a bronchodilator theophylline has been widely recognized since Wijnands et al. (31) observed raised concentrations of theophylline in the plasma of patients concomitantly given enoxacin (ENX; the structure is given in Fig.  1 ). This interaction involves the reduced metabolic clearance resulting from inhibition of theophylline metabolism by ENX (32) . In previous reports (19, 21) , we indicated that a similar interaction can be seen in the rat model and suggested that the neighborhood of a 7-piperazine ring in the ENX molecule, in particular, positions 4Ј and 8 (nitrogen atoms; see Fig. 1 ), are of certain importance in this interaction. However, both in rats (19, 22) and in humans (23, 26, 29, 33) , the effects of other fluoroquinolones with 7-piperazine rings with structures similar to that of ENX are not always the same on in vitro and in vivo theophylline metabolism: ofloxacin and norfloxacin exhibit a slight interaction, and lomefloxacin and sparfloxacin, which are 6,8-difluorinated quinolones, scarcely affect theophylline metabolism.
The present study was designed to clarify the molecular characteristics of ENX responsible for the inhibition of theophylline metabolism. We first investigated the effects of ENX and its seven analogous compounds (the structures of the compounds and their designations are given in Fig. 1 ) on the in vitro conversion of theophylline to its major metabolite, 1,3-dimethyluric acid (1, , by liver microsomes of rats pretreated with 3-methylcholanthrene . This pretreatment enhances theophylline metabolism with a metabolite composition qualitatively similar to that obtained without pretreatment to enable a more precise analysis of 1,3-DMU (19) . Second, the difference spectra of the microsomes in the presence of those compounds were measured to evaluate their tendency to be bound to cytochrome P-450. Lastly, we tried to relate the findings to the molecular conformations and electrostatic potentials of the compounds on the basis of X-ray crystallographic analysis and the molecular orbital method.
MATERIALS AND METHODS
Chemicals. ENX and its seven derivatives ( Fig. 1) were synthesized by our company (9, 13, 17) . The following abbreviations are used for the derivatives: 4Ј-NMe, 4Ј-N-methyl-ENX; 3Ј-Me, 1-cyclopropyl-3Ј-methyl-ENX; 3Ј,5Ј-DMe, 1-cyclopropyl-3Ј,5Ј-dimethyl-ENX; 8-Hy, 8-hydro-ENX (norfloxacin); 8-Fl, 1-cyclopropyl-8-fluoro-ENX; 3Ј-CO, 3Ј-oxo-ENX; 4Ј-NCO, 4Ј-N-acetyl-ENX (3Ј-CO and 4Ј-NCO are metabolites of ENX [35] ). Theophylline and 3-MC were purchased from Wako Pure Industries Ltd. (Osaka, Japan). 1,3-DMU and glucose-6-phosphate (G-6-P) were purchased from Ardrich Chemical Co. (Milwaukee, Wis.). 1-Methylxanthine (1-MX) and 1-methyluric acid (1-MU) were obtained from Fluka AG (Buchs, Switzerland). 7-(2-Hydroxyethyl)-1,3-dimethylxanthine, obtained from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan), was used as an internal standard for high-pressure liquid chromatography (HPLC) determination of theophylline metabolites. G-6-P dehydrogenase and NADP were purchased from Oriental Yeast Co., Ltd. (Tokyo, Japan). The other chemicals obtained commercially were of analytical reagent grade.
Animals. Male Wistar rats weighing 150 to 200 g obtained from Kitayama Rabes Co., Ltd. (Kyoto, Japan), were used. They were pretreated once daily for 4 days with an intraperitoneal injection of 20 mg of 3-MC per kg of body weight dissolved in corn oil and were fasted overnight before sacrifice.
Microsome preparation. Microsomes were prepared as described previously (19) . The protein concentrations were determined by the method of Lowry et al. (16) , with bovine serum albumin used as a standard.
Incubation. An incubation mixture contained 50 mM phosphate buffer (pH 7.4), 0.05 mM EDTA, 4 mM G-6-P, 0.7 mM NADP, 10 U of G-6-P dehydrogenase, 4.7 mg of microsomal proteins, 0.25 mM theophylline, and 0 to 1 mM a fluoroquinolone derivative in a total volume of 3 ml. The mixture was incubated aerobically at 37ЊC for 90 min. The reaction was stopped by the addition of 2 ml of 10% trichloroacetic acid.
Determination of theophylline metabolites. After the addition of trichloroacetic acid, 0.1 ml of the aqueous internal standard solution (100 g/ml) was added to the incubation mixture. The mixture was centrifuged at 2,500 rpm at room temperature for 10 min with a Hitachi 05PR-22 centrifuge and an 03-type angle rotor. The 4-ml supernatant was shaken with 7 ml of chloroform to remove the unreacted theophylline. The aqueous layer was neutralized with 1 M NaOH, and a 30-l portion was injected into the HPLC apparatus.
HPLC was carried out with a Hewlett-Packard (Waldbronn, Germany) HP-1090 system equipped with a UV detector operated at 280 nm. A LiChrosorb RP-8 (250 by 4 mm I [inner diameter]; E. Merck, Darmstadt, Germany) column maintained at 50ЊC was used. The mobile phase consisted of 10 mM sodium acetate and 5 mM tetrabutylammonium hydrogen sulfate adjusted to pH 5.0 with 1 M NaOH and was driven at a flow rate of 1.5 ml/min.
Three metabolites, 1,3-DMU, 1-MX, and 1-MU, were identified from their retention times in comparison with those of the authentic compounds. The calibration curve of each metabolite was linear up to 20 g/ml in the incubation mixture, and the detection limit was 0.1 g/ml, corresponding to 0.2% of the theophylline added. The interday coefficients of variation of the ratios of the peak areas at 0.5 and 5 g/ml (n ϭ 3) to the areas of the internal standards were 7.3 and 2.3%, respectively, for 1,3-DMU, 10.4 and 6.0%, respectively, for 1-MX, and 12.7 and 9.7%, respectively, for 1-MU. The intraday coefficients of variation at 0.5 and 5 g/ml (n ϭ 3) were 7.1 and 2.0%, respectively, for 1,3-DMU, 7.2 and 2.3%, respectively, for 1-MX, and 11.1 and 7.3%, respectively, for 1-MU. The inter-and intraday accuracies of the detected concentrations versus the spiked concentrations indicated above ranged from Ϫ10 to ϩ6% for 1,3-DMU, Ϫ10 to ϩ8% for 1-MX, and Ϫ12 to ϩ12% for 1-MU.
Difference spectra. Difference spectra were measured under aerobic conditions with a Shimadzu (Kyoto, Japan) UV-visible spectrophotometer. Sample and reference cuvettes contained 3 ml of the microsomal suspension at a protein concentration of 1 mg/ml in 0.1 M phosphate buffer (pH 7.4) containing 0.1 mM EDTA. Fluoroquinolone derivatives dissolved in dimethylformamide were added to the sample cuvette (final concentration, 0.1 to 1 mM), and the corresponding volume of the solvent (20 l) was added to the reference cuvette.
Data analysis. The effects of the derivatives on the in vitro theophylline metabolism were evaluated by their 50% inhibitory concentration (IC 50 s) against the 1,3-DMU formation obtained from the linear plot of percent inhibition versus log derivative concentration. The difference spectral data were analyzed by the double-reciprocal plot of the absorbance versus the derivative concentration. The K s value was obtained from the reciprocal of the x-axis intercept. Excel software, version 5.0, was used to fit the data plots on a PC-9801DA computer, and linear least-squares regression provided the highest coefficient of correlation.
X-ray crystallographic analysis of ENX. ENX was subjected to single-crystal X-ray analysis with a view to knowing its solid-state conformation. The coordinates of ENX are available from the authors upon request. Crystal data: a colorless plate crystal of C 15 . All measurements were made on a Rigaku AFC5R diffractometer with graphite monochromated MoK␣ radiation and a 12-kW rotating anode generator. Of the 5,267 reflections which were collected by the Ϫ 2 scan technique to a 2 max value of 120.3Њ, 2,515 were unique (R int ϭ 0.127); equivalent reflections were merged and were corrected for Lorentz and polarization effects. For unit cell determination, 25 reflections in the range 20.9Њ Ͻ 2 Ͻ 34.7Њ were used.
The crystal structure was solved by direct methods by using MITHRIL (8) . The nonhydrogen atoms were refined anisotropically. Hydrogen atoms which were bonded to oxygen or nitrogen were refined isotropically. The final cycle of full-matrix least-squares refinement was based on 957 observed reflections, with I Ͼ 2.00(I) where I is intensity, and 259 variable parameters and converged at R ϭ 0.047 and R w ϭ 0.049. Neutral atom scattering factors, corrected for the real and anomalous scattering, were used for all atoms and were taken from the literature (5) .
Conformational analysis and calculation of electrostatic potential. The X-ray crystallographic data for ENX were used to obtain its molecular conformation. For other derivatives the AM1 semiempirical molecular orbital method was used to determine the most stable molecular conformation with the program MOPAC, version 5.0 (No. 455), with geometry optimization on a Silicon Graphics IRIS 4D/35TG computer. The molecular structure was built up on the basis of the crystallographic data for ENX, pefloxacin (1), or sparfloxacin (18) to obtain the initial atomic coordinates for the molecular orbital calculation. The coordinates for pefloxacin and sparfloxacin were obtained from the Cambridge Structural Database, whose reference codes (REFCODE) for these two compounds are FORGAU and JEKMOB, respectively (2) . Dihedral angles between planes made up by C(6)OC (7)ON(1Ј) bonds and those by C(7)ON(1Ј)OC(2Ј) bonds were then measured. Electrostatic potential was calculated by using charges obtained by the AM1 method.
RESULTS

Metabolites of theophylline formed by microsomes.
The major route of theophylline metabolism by our liver microsome preparation was via 8-hydroxylation to form 1,3-DMU at a rate of 5.67 nmol/mg of protein per h, which accounted for 67% of the total metabolite formation. Two other metabolites were identified as 1-MX and 1-MU and formed via 3-N-demethylation and via 3-N-demethylation plus 8-hydroxylation, representing only 30 and 3% of the total metabolite formation, respectively. ENX was found to inhibit the formation of each metabolite to an extent similar to that in a previous study (19) , as was also the case for its derivatives in our preliminary examinations in the present study. The formation of 1,3-DMU was thus regarded as a reliable indicator that could be used to evaluate the effects of quinolone derivatives in the present in vitro system on theophylline metabolism.
Effects on 1,3-DMU formation. The effects of ENX and its derivatives on the formation of 1,3-DMU are described in Table 1 . The methyl-substituted derivatives 4Ј-NMe, 3Ј-Me, and 3Ј,5Ј-DMe (see Fig. 1 for the structures), as well as ENX, caused a concentration-dependent inhibition of 1,3-DMU formation. When the concentration of these derivatives was 1 mM, the degree of inhibition was about 70%, and their IC 50 s were also similar to each other (about 0.40 mM).
A quinoline-type derivative, 8-Hy, which lacks a nitrogen atom at position 8, compared with a 1,8-naphthyridine-type ENX, gave 51.2% inhibition at 1 mM and an IC 50 of 0. On the other hand, the ENX metabolites 3Ј-CO and 4Ј-NCO (35), which have a carbonyl group at the position vicinal to the 4Ј-nitrogen atom, inhibited 1,3-DMU formation by only 11.5 and 6.0%, respectively, and their IC 50 s were greater than 2 mM.
Effects on difference spectra. The addition of ENX, 4Ј-NMe, 3Ј-Me, and 3Ј,5Ј-DMe (1 mM) produced an absorption peak at 425 nm and a trough peak at 395 nm (Fig. 2) . The type of spectral change is called type II and is a piece of evidence that they serve as a ligand bound to the active site of cytochrome P-450 (27) . The difference in absorbance between 425 and 460 nm caused by these four compounds ranged narrowly from 0.010 to 0.014, and K s values were also in a narrow range of 0.20 to 0.30 mM ( Table 2 ). The analogs 8-Hy and 8-Fl also induced the type II difference spectral changes (Fig. 2) , but the absorbance changes (0.007 and 0.003) were smaller than that induced by ENX, giving larger K s s (0.41 and 0.65 mM, respectively) ( Table 2 ). The affinity for cytochrome P-450 was thus in the order ENX Ͼ 8-Hy Ͼ 8-Fl. On the contrary, 3Ј-CO and 4Ј-NCO did not cause any difference spectral changes.
Molecular structures. The ORTEP (10) drawing of the Xray crystal structure of ENX, with a 50.0% probability of being ellipsoid (hydrogen atoms were given arbitrary thermal parameters for clarity), is presented in Fig. 3 . One molecule ENX crystallized with three water molecules per asymmetric unit and existed in the zwitterionic form, with its carboxylate proton bonded to the nitrogen atom (N4Ј) in the piperazine ring, as shown in Fig. 3 .
Schematic diagrams of the molecular structures and projection diagrams viewed along the N1ЈOC7 bonds of ENX, 8-Hy, and 8-Fl are provided in Fig. 4 . A striking difference could be seen in the molecular conformation around position 7 of the compounds. The piperazine ring of ENX was shown to be almost coplanar to the naphthyridine ring. The energy of 8-Hy was minimized when the piperazine ring was slightly twisted out of a plane of the quinoline ring. The piperazine ring of 8-Fl was forced to be virtually perpendicular to the quinoline ring by steric hindrance between the fluorine and the hydrogen on the piperazine ring. Dihedral angles between the piperazine ring and the naphthyridine or quinoline ring of ENX, 8-Hy, and 8-Fl were calculated to be 38, 49, and 108Њ, respectively. Those of the methyl-and carbonyl-substituted derivatives were almost equal to that of ENX (data not shown).
Electrostatic potentials. Figure 5 provides the electrostatic potentials of ENX, 8-Hy, 3Ј-CO, and 4Ј-NCO. Solid and dashed lines represent isopotential contours at Ϫ1 and ϩ1 kcal/mol, respectively. 3Ј-CO and 4Ј-NCO were found to hold a broadened negatively charged potential distribution around their 4Ј-nitrogen atoms, which is clearly different from the situation for ENX and 8-Hy, which had a highly localized one. These results suggest that the carbonyl group at the vicinal 
DISCUSSION
In a previous study (19) , we found that an ENX analog without the 4Ј-nitrogen atom in the 7-piperazine ring (i.e., piperidine substituent at position 7) does not inhibit rat liver microsomal theophylline metabolism to 1,3-DMU and that the presence of an 8-substituent such as fluorine somewhat weakens the inhibitory potency. These findings suggest that positions 4Ј and 8 or its surroundings of ENX can play an important role in the inhibition of theophylline metabolism. The present study was designed to clarify the molecular characteristics of ENX responsible for the inhibition of theophylline metabolism.
As shown in Table 1 , methyl-substituted derivatives (4Ј-NMe, 3Ј-Me, and 3Ј,5Ј-DMe) inhibited 1,3-DMU formation to a degree similar to that at which ENX inhibited 1,3-DMU formation, indicating no steric effects of the methyl group around the 4Ј-nitrogen atom. In contrast, as observed in 3Ј-CO and 4Ј-NCO, substitution of a carbonyl group remarkably weakened the inhibitory potency. In these compounds, the negatively charged electrostatic potential around the 4Ј-nitrogen atom was found to be rather broadened in comparison with that in ENX (Fig. 5) , which suggests a lack of basicity of the 4Ј-nitrogen atom because of an electron-withdrawal effect of the vicinal carbonyl group. The basicity is considered to be an important characteristic for the inhibition of theophylline metabolism.
Recently, Fuhr et al. (7) have demonstrated that substitution of alkyl groups on the 7-piperazine rings of fluoroquinolones most dramatically decreases their inhibitory potencies against caffeine metabolism by human liver microsomes. Because they treated the microsomes primarily with 4Ј-N-methylated fluoroquinolones except ENX and our data were limited to ENX derivatives, a direct comparison is impossible. However, it is interesting that the 4Ј-N-methyl form of a potent inhibitor (ciprofloxacin) exhibits a smaller decrease in inhibitory potency of caffeine metabolism from the level of inhibition exhibited by the parent compound in comparison with that of a moderate inhibitor (norfloxacin) (7) . Since ENX inhibition is shown to be more potent than ciprofloxacin inhibition (7), the effect of the 4Ј-methylation of ENX may be less on caffeine metabolism by human liver microsomes.
4Ј-NMe, 3Ј-Me, and 3Ј,5Ј-DMe produced type II spectral changes, and the magnitudes of the changes were almost equal to that of ENX, while 3Ј-CO and 4Ј-NCO failed to cause any difference spectral changes ( Fig. 2 and Table 2 ). These results indicate that ENX and its methylated derivatives can approach the active site of cytochrome P-450 but that 3Ј-CO and 4Ј-NCO cannot (27) and suggest that the derivatives with the ability to be bound to the catalytic center of cytochrome P-450 inhibit theophylline metabolism. Cytochrome P-450 involves a porphyrin ring with a heme iron at the catalytic center (24) , and the heme iron has high electrophilicity and the ability to coordinate to basic, nucleophilic, or negatively charged moieties as the sixth ligand (4, 6) . The basic 4Ј-nitrogen atom of the ENX derivatives is most likely to be a moiety that binds to the heme iron. We reported previously that theophylline also causes a type II difference spectral change and that ENX competitively inhibits theophylline binding to the heme iron (19) , which can explain the competitive-type inhibition of theophylline metabolism by ENX (19, 29) . The basicity of the 4Ј-nitrogen atom is therefore essential to the binding interaction with theophylline at the catalytic center of cytochrome P-450.
The derivatives 8-Hy and 8-Fl inhibited 1,3-DMU formation to a smaller extent than ENX did. In addition, their type II difference spectral changes were quite small ( Table 2) . Inhibitory potentials of 1,3-DMU formation decreased in the order of ENX Ͼ 8-Hy Ͼ 8-Fl, which was in parallel with the order of affinity to cytochrome P-450, as represented by K s values (Table 2). In addition, their molecular conformations were quite different around the 7-piperazine ring, and the planarities of the whole molecules decreased in the same order (ENX Ͼ 8-Hy Ͼ 8-Fl) (Fig. 4) . These findings indicate that the planar conformation is also one of the dominant factors determining the inhibitory potential of theophylline metabolism.
Crystal structures of pefloxacin (1) and sparfloxacin (18) have demonstrated that dihedral angles between the piperazine and the quinoline are 51Њ for pefloxacin and 108Њ for sparfloxacin, which are almost the same as those for 8-Hy (49Њ) and 8-Fl (108Њ), respectively. It was reported that pefloxacin weakly interacts with theophylline in humans (23) and that sparfloxacin has practically no effect on theophylline pharmacokinetics in humans (30) and rats (20) . Those facts agree with the present findings, proposing the importance of the molecular conformation of fluoroquinolones in the interaction with theophylline.
Lewis et al. (14) reported that both substrates (containing theophylline) and inhibitors of 3-MC-inducible cytochrome P-450 isozymes, CYP1A1 and CYP1A2, may possess planar conformations. Moreover, Kaminsky et al. (12) demonstrated that cytochrome P-450 BNF-B (CYP1A1) induced by 7,8-benzoflavon preferentially metabolizes coplanar dichlorobiphenyl compounds, while PB-B (CYP2B1) induced by phenobarbital preferentially metabolizes noncoplanar ones. Conformational differences in the planarities of dichlorobiphenyl compounds depend only on whether two o-chloro substituents are present. The planar ENX molecule probably behaves in the possibly narrow catalytic site of CYP1A1 and/or CYP1A2, like the coplanar dichlorobiphenyl compounds but, may be not easily metabolized by the isozymes per se (35) , which can explain its potent inhibitory effect on theophylline metabolism. The planar conformation is thus favorable for approaching the catalytic center.
Of many cytochrome P-450 isozymes, CYP1A1 or CYP1A2 primarily metabolize(s) theophylline in humans (3, 25) and conceivably in rats (15, 34) . The present study did not intend to distinguish which of the two isozymes was mainly involved in the interaction, but it would occur mainly at the catalytic center of CYP1A2. This presumption stands upon the data that either ENX ( Fig. 2A) or theophylline (19) caused clear type II difference spectral changes showing ligand binding to the heme iron, which is considered to have a low spin state. Since the intact CYP1A2 but not CYP1A1 is present as a high-spin-state type (11, 28) , it is likely that a change in the CYP1A2 spin state was measured in the present spectral study.
In conclusion, the planar conformations of fluoroquinolones such as ENX and the basicity of the 4Ј-nitrogen atom are dominant factors giving rise to the interaction with theophylline. The planarity is a favorable characteristic for approaching the catalytic center of CYP1A1 and/or CYP1A2, and the basicity is a favorable characteristic for binding to the heme iron of the enzyme(s).
